Clinical Trial Update: A Novel Therapeutic Target for Alzheimer's Disease in Men and Women 50-85 Years of Age. [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial investigating a novel therapeutic target for Alzheimer's disease in adults aged 50-85 was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cognitive Impairment

Snippet

Sponsor: University of Rhode Island | Conditions: Mild Cognitive Impairment, Mild Alzheimer's Disease | Phase 1 | Status: WITHDRAWN